Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Gilead Science's sulfone HIV protease inhibitors

July 26, 1996

Positive phase I/II results for PDT's SnET2 in AIDS-associated Kaposi's sarcoma patients

July 19, 1996

Interim results from ALRT-1057 phase I/II trials

July 19, 1996

CryptoGam enters phase II for cryptosporidiosis in AIDS patients

July 19, 1996

Hybridon's GEM-91 inhibits various steps in HIV-1 replication

July 19, 1996

Cel-Sci's HGP-30 vaccine associated with IgG3 isotype antibody response

July 19, 1996

Zadaxin/zidovudine/interferon alpha combination enhances immune system

July 19, 1996

Theratechnologies' AIDS gene therapy shows promising results

July 19, 1996

Triple anti-HIV therapy shows positive results

July 19, 1996

Protease inhibitor plus Epivir/Retrovir cocktail shows positive anti-HIV results

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...